TransMedics Group, Inc.

Healthcare

NASDAQ:TMDX · NASDAQ Global Market

Market Cap $2.62B Beta 1.88 P/E (TTM) 15.8

$78.79 +8.11%

+$5.94 today

52W Low $60.11High $156.00

Vol 1.72M · Avg 1.32M

EPS (TTM) $5.00Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-36.23%

Period High

$150.42

Period Low

$62.04

Latest

$78.79

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Bruker Corporation

NASDAQ:BRKR

$8.56B

Glaukos Corporation

NYSE:GKOS

$7.69B

Kymera Therapeutics, Inc.

NASDAQ:KYMR

$7.45B

Oscar Health, Inc.

NYSE:OSCR

$7.32B

Immunovant, Inc.

NASDAQ:IMVT

$7.14B

Hinge Health, Inc.

NYSE:HNGE

$5.24B

Indivior Pharmaceuticals Inc

NASDAQ:INDV

$4.78B

Akero Therapeutics, Inc.

AKRO

$4.50B

NewAmsterdam Pharma Company N.V.

NASDAQ:NAMS

$3.48B

Option Care Health, Inc.

NASDAQ:OPCH

$3.45B

What is the latest TMDX filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does TMDX have?

Intrinsic Alpha currently shows 20 recent filings for TMDX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.